A2 Corp, which claims a health benefit from the protein variant in its milk, more than doubled annual profit by expanding in Australia and is looking at building its footprint in China and Britain for its next stage of growth.
Net profit climbed to $4.4 million, or 0.74c a share, in the 12 months ended June 30, from $2.1 million, or 0.4c, a year earlier, the company said.
Revenue jumped 44 per cent to $64 million, with Australian sales accounting for about 98 per cent. A2 increased its market share to 5.8 per cent by value of fresh milk sales.
"The first two months [of trading] continue to be positive in respect of sales and we'll look for more market share growth to come," managing director Geoff Babidge said.
"It will be interesting to see whether the momentum we've have in the past can be maintained - obviously it's been an extremely strong rate of sales growth and we're optimistic it can continue."
